Violation Tracker Parent Company Summary
Parent Company Name:
Bristol-Myers Squibb
Ownership Structure:
publicly traded (ticker symbol BMY)
Headquartered in:
New York
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
Penalty total since 2000:
$1,027,177,783
Number of records:
19
| Top 10 Primary Offense Types | Penalty Total | Number of Records |
|---|---|---|
| off-label or unapproved promotion of medical products | $515,000,000 | 1 |
| fraud | $300,000,000 | 1 |
| accounting fraud or deficiencies | $150,000,000 | 1 |
| benefit plan administrator violation | $41,220,000 | 1 |
| Foreign Corrupt Practices Act | $14,000,000 | 1 |
| environmental violation | $3,834,983 | 10 |
| consumer protection violation | $2,100,000 | 1 |
| drug or medical equipment safety violation | $1,000,000 | 1 |
| export control violation | $16,200 | 1 |
| economic sanction violation | $6,600 | 1 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.
Associated Names:
BRISTOL MYERS SQUIBB; BRISTOL MYERS SQUIBB MEDICAL IMAGING; BRISTOL MYERS SQUIBB MFG; Briston-Myers Squibb; DUPONT PHARMACEUTICALS; ER SQUIBB AND SONS
Links:
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
Download results as 
or XML
or XML
| Company | Primary Offense Type | Year | Agency |
Penalty Amount |
|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | environmental violation | 2000 | EPA | $5,000 |
| E.R. SQUIBB & SONS, LLC. | environmental violation | 2013 | EPA | $5,950 |
| DuPont Pharmaceuticals Company | economic sanction violation | 2004 | OFAC | $6,600 |
| BRISTOL-MYERS SQUIBB CO | environmental violation | 2001 | EPA | $7,600 |
| E.R. Squibb & Sons LLC | environmental violation | 2009 | EPA | $8,125 |
| Bristol-Myers Squibb Medical Imaging, Inc. | export control violation | 2004 | BIS | $16,200 |
| BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | environmental violation | 2009 | EPA | $19,538 |
| BRISTOL-MYERS SQUIBB CO | environmental violation | 2011 | EPA | $20,000 |
| Bristol Myers Squibb Manufacturing Company | environmental violation | 2008 | EPA | $52,000 |
| Bristol Myers Squibb Company | environmental violation | 2008 | EPA | $66,770 |
| Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
| Bristol-Myers Squibb Company | consumer protection violation | 2009 | FTC | $2,100,000 |
| Bristol-Myers Squibb | environmental violation | 2009 | EPA | (*) $2,328,154 |
| Bristol-Myers Squibb | environmental violation | 2008 | EPA | $3,650,000 |
| Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
| Briston-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
| Bristol-Myers Squibb Company | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
| Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
| Bristol-Myers Squibb Company | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |
Download results as or XML
or XML
